🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨🥁🔔 Hot off the press! 🔔 We are thrilled to share the pre-proof version of our latest editorial in ESMO - Eur. Oncology flagship journal Annals of Oncology 👉"The Best Management for Most Patients with Incurable Cancer is on a Clinical Trial." Razelle Kurzrock, MD 👉Cancer clinical trials are

Today we launch the PoweRD 2 Cure ALK+ Lung Cancer TeamLab! Uniting researchers from Dana-Farber MD Anderson Cancer Center Koch Institute at MIT Sidney Kimmel Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center Boston Children's Mass General Cancer Center CU Cancer Center @VUMC_Cancer in radical collaboration to target residual lung

Tackling big problems requires radical collaboration 💪. The “PoweRD 2 Cure” team strives to overcome minimal residual disease (MRD) observed with #targetedtherapy in #lungcancer. Powerhouse team to conquer an urgent, unmet clinical question. Break Through Cancer ALK Positive

Huge disruption to heath care pending. Telehealth coverage will largely expire March 31 unless current administration reverses course. Essential for so many patients, especially those with cancer on Medicare. Patients already being cancelled from my clinic search.app/nMDQSnG1iTNVKu…

It's clear that many do not understand what NIH-funded research does to improve health. It's time to revive a study published 10 years ago that provides incredible information about this. link in the comment Every single new drug approved by the FDA from 2010–2016 was built on

Had an awesome time at dinner conversations with folks on the ASCO Lung scientific committee track Melina Marmarelis Misty Dawn Shields Sandip Patel MD FASCO Shankar Siva Natalie Vokes and others ! Theme of the evening “sabbaticals” 😀

It was a pleasure to spend the day ASCO planning the metastatic NSCLC program with this amazing group (missing Toby Campbell). Looking forward to an exciting #ASCO25 !

The landscape for EGFR-mutant advanced NSCLC is evolving. At #TexasLung25, Dr. Natalie Vokes joins a panel to discuss the latest data and real-world applications. Join the discussion April 10-12, 2025. Register now for this 2-day CE-accredited conference: hubs.la/Q03czWTx0 #LCSM

Thanks to Targeted Oncology for the invitation, had a great time reviewing this data! More nuanced clinical decisions to be made with our patients as our options for front-line EGFR have increased

The treatment landscape for EGFR-mutant advanced NSCLC is shifting—are you up to date? At #TexasLung25, Dr. Karen Kelly leads a must-attend session featuring expert insights from Drs. Xiuning Le MD PhD, Rachel E. Sanborn, MD, Erminia Massarelli, Julia Rotow MD, Edgardo S. Santos, M.D., FACP, FASCO, and Natalie Vokes.

Day 1 #TexasLung25 at Austin City Limits is underway! Outstanding faculty discussion on WHO and WHEN to intensify therapy for patients who have EGFR altered lung cancer: 🔵 Brain metastases? 🔵 Liver metastases? 🔵 EGFR L858R? P53? 🔵 Does age matter? IASLC Stephen V Liu, MD

Great start to TLC Conference w/ talks on evolving landscape of 1L & 2L+ tx for pts w/ #EGFR-mutant #NSCLC 💠When to use upfront escalation w/ FLAURA2 & MARIPOSA balanced w/ tox profile eg🧠mets 💠Trials for exon 20 ins; tx needed for nonclassical mut 💠Data on ADCs & ivonescimab

MD Anderson Cancer Center thoracic oncology team does #TexasLung25! TLC Conference #TinaCascone Stephen V Liu, MD

Confused about immunotherapy? Listen to Natalie Vokes and jj singleton getting into the nuts and bolts of how it works and how it feels to get it! Ep 09: What Immunotherapy Really Means for Patients | Cracking Cancer Po... youtu.be/2YFlww-N29M?si… via YouTube

Great chat with Natalie Vokes and jj singleton about immunotherapy. What it is and what it’s like to receive it from the experts!

Come see us at #ASCO25 at the MD Anderson Cancer Center Booth! Natalie Vokes Ferdinandos Skoulidis #EndCancer

Happening soon at #ASCO25!! Dr. Bruna Pellini, MD (Moffitt Cancer Center) and Dr. Natalie Vokes (MD Anderson Cancer Center) will be chairing the metastatic NSCLC session! Exciting data on the way! ASCO

Best way to start #ASCO25 Sunday is with new NSCLC data! Come by Arie Crown at 8 for exciting abstracts and discussion, cochairing with Bruna Pellini, MD #LCSM

Great to meet with our lung cancer experts at MD Anderson Cancer Center and thanks for the consult! Eric K. Singhi, MD Natalie Vokes #ASCO2025

🌟 A remarkable oral session at #ASCO25 showcasing that the future of lung cancer care is bright! 👏 Hats off to the incredible chairs Bruna Pellini, MD Natalie Vokes, all speakers and insightful discussants Ticiana Batista (Leal) Vanita Noronha, MBBS MD DM Marcelo Corassa, MD. , who brought both science of